Emricasan

Emricasan Uses, Dosage, Side Effects, Food Interaction and all others data.

Emricasan is the first caspase inhibitor tested in human which has received orphan drug status by FDA. It is developed by Pfizer and made in such a way that it protects liver cells from excessive apoptosis.

Table Of contents

• Emricasan
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Emricasan
Generic	Emricasan
Emricasan Other Names	Emricasan, Emricasán, Emricasanum
Type
Formula	C26H27F4N3O7
Weight	Average: 569.51 Monoisotopic: 569.178512873
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in hepatitis (viral, C), liver disease, and transplantation (organ or tissue).

How Emricasan works

IDN-6556 significantly improves markers of liver damage in patients infected with the Hepatitis C virus (HCV), an infection that affects up to 170m patients worldwide. IDN-6556 represents a new class of drugs that protect the liver from inflammation and cellular damage induced by viral infections and other causes. Various studies have also shown that it significantly lowers aminotransferase activity in HCV patients and appeared to be well tolerated.

Innovators Monograph

You find simplified version here Emricasan